2026 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2026-10-08

New international consensus updates framework for CAR T-cell therapy in severe autoimmune diseases

Experts from EBMT, ISCT and JACIE, with representatives from EULAR and ECTRIMS, have published updated recommendations supporting careful patient selection, multidisciplinary care and long-term follow-up as CAR T-cell therapy expands beyond cancer. An international multidisciplinary group of 31 experts has updated consensus recommendations for using chimeric antigen receptor (CAR) T-cell therapy in people with severe,

No Comments InCAR-T

PIER MARIA FORNASARI
2026-10-08

Optogenetic therapy shows safe step forward in vision restoration

Five years after a landmark result in a single patient, new findings from the first treated cohort show that optogenetic vision restoration can work beyond an individual case. Scientists have taken another important step toward restoring vision in people with certain inherited forms of blindness. In a study published in the New England Journal of

No Comments InGENE THERAPY RESEARCH

PIER MARIA FORNASARI
2026-10-02

Possible New Target for Sickle Cell Disease and Beta Thalassemia Treatment identified by Harvard Medical School Researchers

Researchers identify additional gene controlling production of fetal hemoglobin Harvard Medical School researchers at Boston Children’s Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin. Two FDA-approved gene therapies reactivate the production of

No Comments InRESEARCH

PIER MARIA FORNASARI
2026-10-02

New England Journal of Medicine: REACT reveals that silent atherosclerosis already affects 1 in 13 young adults aged 18 to 29 and progresses rapidly from the menopause

The research, presented in a Hot Line session at the European Society of Cardiology Congress in Munich and published simultaneously in The New England Journal of Medicine, proposes a paradigm shift towards prevention based on early detection through vascular imaging Atherosclerosis, the process underlying most cardiovascular diseases, begins long before the first symptoms appear. An international

No Comments InWELLNESS

PIER MARIA FORNASARI
2026-10-01

Retatrutide, new Triple Hormone Receptor Agonist, Improves Weight Loss up to 30%, Knee Osteoarthritis Pain, Sleep Apnea Versus Placebo

Retatrutide treatment results in substantial weight loss among patients with obesity, as well as reduced pain in patients with knee osteoarthritis and reduced apnea-hypopnea events in patients with obstructive sleep apnea, according to the TRIUMPH-1 study.1 Earlier phase 2 trials including patients with obesity have indicated that once-weekly subcutaneous retatrutide resulted in substantial weight reductions

No Comments InRESEARCH WELLNESS

PIER MARIA FORNASARI
2026-09-30

American College of Cardiology Scientific Statement Says Overall Diet Quality Key to Maintaining Heart Health

A healthy, balanced dietary pattern, rather than one focused on individual nutrients or foods, is key to maintaining heart health, according to a new ACC Scientific Statement on Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease. Read the full Statement in JACC. Key Takeaways The Statement reviews current evidence on nutrition and

No Comments InWELLNESS

PIER MARIA FORNASARI
2026-09-30

Research spotlight: How exercise protects joints in aging-related osteoarthritis

Hirotaka Iijima, PhD, PT, and Fabrisia Ambrosio, PhD, MPT, of the Discovery Center for Musculoskeletal Recovery within the Department of Physical Medicine and Rehabilitation at Mass General Brigham, are the lead and senior authors of a paper published in Nature Aging, “Exercise enhances aged chondrocyte health through microRNA29–enriched extracellular vesicles“. Osteoarthritis is one of the

One comment InWELLNESS

PIER MARIA FORNASARI
2026-09-29

EU recommends regular heart checks from age 35

Brussels cites nicotine products and alcohol as specific risk factors. The European Union on 28th September 2026 recommended regular health checks for people aged 35 and over and at least one screening for heart disease for those under 35. The EU wants most citizens to be screened earlier for heart disease and other overlapping conditions,

No Comments InWELLNESS

PIER MARIA FORNASARI
2026-09-29

How much do Americans spend on GLP-1 medications? VCU medical students measure drug affordability

The study reveals trends in health spending, which soared to nearly $65 billion in 2023 for the popular weight-loss drugs. Among their findings: Nearly 1 in 5 of GLP-1 users spent at least 10% of their household income on the medications. The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss

No Comments InWELLNESS

PIER MARIA FORNASARI
2026-09-27

First severe human case of Oya virus reported in China. The new case involves a 54-year-old woman who worked at a goose farm in Qingyuan, in China’s Guangdong province.

China has confirmed the first documented case of a severe human infection caused by the Oya virus, a pathogen belonging to the Orthobunyavirus genus that had previously been identified primarily in mosquitoes and biting midges. This case provides insight into the virus’s effects and how it can be transmitted to humans. The case is published

No Comments InWELLNESS

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2026-10-08

New international consensus updates framework for CAR T-cell therapy in severe autoimmune diseases

Optogenetic therapy shows safe step forward in vision restoration

Possible New Target for Sickle Cell Disease and Beta Thalassemia Treatment identified by Harvard Medical School Researchers

New England Journal of Medicine: REACT reveals that silent atherosclerosis already affects 1 in 13 young adults aged 18 to 29 and progresses rapidly from the menopause

Retatrutide, new Triple Hormone Receptor Agonist, Improves Weight Loss up to 30%, Knee Osteoarthritis Pain, Sleep Apnea Versus Placebo

American College of Cardiology Scientific Statement Says Overall Diet Quality Key to Maintaining Heart Health

Research spotlight: How exercise protects joints in aging-related osteoarthritis

EU recommends regular heart checks from age 35

How much do Americans spend on GLP-1 medications? VCU medical students measure drug affordability

First severe human case of Oya virus reported in China. The new case involves a 54-year-old woman who worked at a goose farm in Qingyuan, in China’s Guangdong province.